| Organism name | Asclepias syriaca | 
|---|---|
| Genus | Asclepias | 
| Family | Apocynaceae | 
| Kingdom | Plantae | 
| Linked NCBI taxonomy name | Asclepias syriaca | 
|---|---|
| Linked NCBI taxonomy ID | 48545 | 
| Linked level | species | 
| Family in NCBI taxonomy | Apocynaceae | 
|---|---|
| ID | 4056 | 
| Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae | 
|---|---|
| ID | 33090 | 
| Plant class | asterids | 
|---|---|
| ID | 71274 | 
| KNApSAcK ID | name | ChEMBL link | CTD link | # of proteins in ChEMBL interaction / related OMIM / related KEGG DISEASE | # of genes in CTD interaction / related diseases | KCF-S cluster | phytochemical cluster | figure | 
|---|---|---|---|---|---|---|---|---|
| C00013912   | Isorhamnetin 3-xylosyl-(1->2)-galactoside / Quercetin 3'-methyl ether 3-xylosyl-(1->2)-galactoside / 5,7-Dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-3-[(2-O-beta-D-xylopyranosyl-beta-D-galactopyranosyl)oxy]-4H-1-benzopyran-4-one | No. 1 | No. 15 |   | ||||
| C00003604   | Aspecioside | No. 109 | No. 56 |   | ||||
| C00005081   | 4'',5''-Dihydro-3,5,3',4'-tetrahydroxy-4'',6'',6''-trimethylpyrano[2,3:7,8]flavone | No. 139 |   | |||||
| C00001240   | Vaccenic acid | No. 184 | No. 68 |   | ||||
| C00002057   | Nicotine | CHEMBL3 CHEMBL9732 CHEMBL440464 CHEMBL1628647 | D009538 | 131 / 72 / 55 | 370 / 191 | No. 2084 | No. 1 |   | 
| accession | description | class description | KNApSAcK metabolite in interactions | # of diseases (OMIM / KEGG) | 
|---|---|---|---|---|
| P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00002057 | 1 / 0 | 
| Q9Y6L6 | Solute carrier organic anion transporter family member 1B1 | Electrochemical transporter | C00002057 | 1 / 0 | 
| O15244 | Solute carrier family 22 member 2 | Drug uniporter | C00002057 | 0 / 0 | 
| O94956 | Solute carrier organic anion transporter family member 2B1 | Unclassified protein | C00002057 | 0 / 0 | 
| P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00002057 | 2 / 0 | 
| P21728 | D(1A) dopamine receptor | Dopamine receptor | C00002057 | 0 / 0 | 
| P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00002057 | 0 / 3 | 
| Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00002057 | 2 / 2 | 
| P08246 | Neutrophil elastase | S1A | C00002057 | 2 / 1 | 
| P33765 | Adenosine receptor A3 | Adenosine receptor | C00002057 | 0 / 0 | 
| Q16539 | Mitogen-activated protein kinase 14 | p38 | C00002057 | 0 / 0 | 
| P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00002057 | 0 / 0 | 
| P29466 | Caspase-1 | C14 | C00002057 | 0 / 0 | 
| P17252 | Protein kinase C alpha type | Alpha | C00002057 | 0 / 0 | 
| P27361 | Mitogen-activated protein kinase 3 | Erk | C00002057 | 0 / 0 | 
| P14780 | Matrix metalloproteinase-9 | M10A | C00002057 | 2 / 2 | 
| O15245 | Solute carrier family 22 member 1 | Drug uniporter | C00002057 | 0 / 0 | 
| P02545 | Prelamin-A/C | Unclassified protein | C00002057 | 11 / 10 | 
| P00918 | Carbonic anhydrase 2 | Lyase | C00002057 | 1 / 2 | 
| P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00002057 | 0 / 1 | 
| P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00002057 | 1 / 1 | 
| P25021 | Histamine H2 receptor | Histamine receptor | C00002057 | 0 / 0 | 
| P35367 | Histamine H1 receptor | Histamine receptor | C00002057 | 0 / 0 | 
| Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00002057 | 1 / 0 | 
| P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00002057 | 0 / 0 | 
| P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00002057 | 0 / 0 | 
| P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00002057 | 0 / 0 | 
| P32297 | Neuronal acetylcholine receptor subunit alpha-3 | CHRN alpha | C00002057 | 1 / 0 | 
| P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00002057 | 0 / 0 | 
| P06241 | Tyrosine-protein kinase Fyn | Src | C00002057 | 0 / 0 | 
| Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00002057 | 0 / 0 | 
| P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00002057 | 0 / 1 | 
| P30926 | Neuronal acetylcholine receptor subunit beta-4 | CHRN beta | C00002057 | 0 / 0 | 
| Q07001 | Acetylcholine receptor subunit delta | CHRN delta | C00002057 | 3 / 2 | 
| P43681 | Neuronal acetylcholine receptor subunit alpha-4 | CHRN alpha | C00002057 | 1 / 1 | 
| P07510 | Acetylcholine receptor subunit gamma | CHRN gamma | C00002057 | 2 / 1 | 
| P17787 | Neuronal acetylcholine receptor subunit beta-2 | CHRN beta | C00002057 | 1 / 1 | 
| P02708 | Acetylcholine receptor subunit alpha | CHRN alpha | C00002057 | 3 / 2 | 
| P11230 | Acetylcholine receptor subunit beta | CHRN beta | C00002057 | 2 / 1 | 
| P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00002057 | 1 / 8 | 
| P14416 | D(2) dopamine receptor | Dopamine receptor | C00002057 | 2 / 0 | 
| P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00002057 | 0 / 0 | 
| P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00002057 | 0 / 0 | 
| P41145 | Kappa-type opioid receptor | Opioid receptor | C00002057 | 0 / 0 | 
| Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00002057 | 0 / 0 | 
| P29274 | Adenosine receptor A2a | Adenosine receptor | C00002057 | 0 / 0 | 
| P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00002057 | 0 / 0 | 
| P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00002057 | 1 / 1 | 
| P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00002057 | 0 / 0 | 
| P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00002057 | 1 / 0 | 
| P00352 | Retinal dehydrogenase 1 | Enzyme | C00002057 | 0 / 0 | 
| P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00002057 | 0 / 0 | 
| Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00002057 | 0 / 0 | 
| P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00002057 | 2 / 0 | 
| O75496 | Geminin | Unclassified protein | C00002057 | 0 / 0 | 
| P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00002057 | 0 / 0 | 
| P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00002057 | 0 / 0 | 
| P21917 | D(4) dopamine receptor | Dopamine receptor | C00002057 | 0 / 0 | 
| P30988 | Calcitonin receptor | Calcitonin receptor | C00002057 | 0 / 0 | 
| P35462 | D(3) dopamine receptor | Dopamine receptor | C00002057 | 1 / 0 | 
| P41143 | Delta-type opioid receptor | Opioid receptor | C00002057 | 0 / 0 | 
| P46098 | 5-hydroxytryptamine receptor 3A | NS | C00002057 | 0 / 0 | 
| Q92731 | Estrogen receptor beta | NR3A2 | C00002057 | 0 / 1 | 
| P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00002057 | 0 / 0 | 
| P25101 | Endothelin-1 receptor | Endothelin receptor | C00002057 | 0 / 0 | 
| P30411 | B2 bradykinin receptor | Bradykinin receptor | C00002057 | 0 / 0 | 
| P10145 | Interleukin-8 | Secreted protein | C00002057 | 0 / 0 | 
| P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00002057 | 1 / 0 | 
| P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00002057 | 0 / 0 | 
| P08311 | Cathepsin G | S1A | C00002057 | 0 / 0 | 
| Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00002057 | 1 / 0 | 
| P03956 | Interstitial collagenase | M10A | C00002057 | 0 / 1 | 
| P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00002057 | 0 / 0 | 
| P83916 | Chromobox protein homolog 1 | Unclassified protein | C00002057 | 0 / 0 | 
| Q9NPD5 | Solute carrier organic anion transporter family member 1B3 | Electrochemical transporter | C00002057 | 1 / 0 | 
| P04150 | Glucocorticoid receptor | NR3C1 | C00002057 | 0 / 1 | 
| P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00002057 | 2 / 0 | 
| P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00002057 | 0 / 0 | 
| P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00002057 | 0 / 0 | 
| P31645 | Sodium-dependent serotonin transporter | Serotonin | C00002057 | 2 / 0 | 
| P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00002057 | 5 / 9 | 
| P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00002057 | 1 / 0 | 
| P21452 | Substance-K receptor | Neurokinin receptor | C00002057 | 0 / 0 | 
| P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00002057 | 0 / 0 | 
| P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00002057 | 3 / 0 | 
| P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00002057 | 0 / 0 | 
| P36544 | Neuronal acetylcholine receptor subunit alpha-7 | CHRN alpha | C00002057 | 0 / 0 | 
| P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00002057 | 1 / 0 | 
| P28482 | Mitogen-activated protein kinase 1 | Erk | C00002057 | 0 / 0 | 
| P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00002057 | 2 / 1 | 
| P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00002057 | 0 / 0 | 
| Q92887 | Canalicular multispecific organic anion transporter 1 | Unclassified protein | C00002057 | 1 / 1 | 
| O75762 | Transient receptor potential cation channel subfamily A member 1 | Unclassified protein | C00002057 | 1 / 0 | 
| P51449 | Nuclear receptor ROR-gamma | Nuclear hormone receptor subfamily 1 group F member 3 | C00002057 | 0 / 0 | 
| O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00002057 | 0 / 0 | 
| P03372 | Estrogen receptor | NR3A1 | C00002057 | 1 / 1 | 
| P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00002057 | 1 / 0 | 
| P22303 | Acetylcholinesterase | Hydrolase | C00002057 | 1 / 0 | 
| P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00002057 | 0 / 0 | 
| P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00002057 | 0 / 0 | 
| P35372 | Mu-type opioid receptor | Opioid receptor | C00002057 | 0 / 0 | 
| P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00002057 | 0 / 0 | 
| P25103 | Substance-P receptor | Neurokinin receptor | C00002057 | 0 / 0 | 
| P25105 | Platelet-activating factor receptor | PAF receptor | C00002057 | 0 / 0 | 
| P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00002057 | 0 / 0 | 
| P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00002057 | 1 / 1 | 
| P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00002057 | 0 / 1 | 
| P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00002057 | 0 / 0 | 
| P10636 | Microtubule-associated protein tau | Unclassified protein | C00002057 | 4 / 3 | 
| Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00002057 | 0 / 0 | 
| P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00002057 | 1 / 1 | 
| P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00002057 | 0 / 0 | 
| P30542 | Adenosine receptor A1 | Adenosine receptor | C00002057 | 0 / 0 | 
| P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00002057 | 0 / 0 | 
| P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00002057 | 1 / 1 | 
| P06239 | Tyrosine-protein kinase Lck | Src | C00002057 | 0 / 1 | 
| P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00002057 | 0 / 0 | 
| Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00002057 | 0 / 0 | 
| Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00002057 | 1 / 1 | 
| Q13951 | Core-binding factor subunit beta | Unclassified protein | C00002057 | 0 / 1 | 
| Q01196 | Runt-related transcription factor 1 | Unclassified protein | C00002057 | 1 / 4 | 
| Q15822 | Neuronal acetylcholine receptor subunit alpha-2 | CHRN alpha | C00002057 | 1 / 1 | 
| Q9H015 | Solute carrier family 22 member 4 | Unclassified protein | C00002057 | 1 / 1 | 
| O76082 | Solute carrier family 22 member 5 | Unclassified protein | C00002057 | 1 / 2 | 
| Q8WXA8 | 5-hydroxytryptamine receptor 3C | NS | C00002057 | 0 / 0 | 
| Q70Z44 | 5-hydroxytryptamine receptor 3D | NS | C00002057 | 0 / 0 | 
| O95264 | 5-hydroxytryptamine receptor 3B | NS | C00002057 | 0 / 0 | 
| A5X5Y0 | 5-hydroxytryptamine receptor 3E | NS | C00002057 | 0 / 0 | 
| Q05901 | Neuronal acetylcholine receptor subunit beta-3 | CHRN beta | C00002057 | 0 / 0 | 
| P30532 | Neuronal acetylcholine receptor subunit alpha-5 | CHRN alpha | C00002057 | 1 / 0 | 
| Q13148 | TAR DNA-binding protein 43 | Unclassified protein | C00002057 | 1 / 1 | 
| gene | gene name | gene description | KNApSAcK metabolite in interactions | 
|---|---|---|---|
| 9625 | AATK, AATYK, AATYK1, LMR1, LMTK1, p35BP | apoptosis-associated tyrosine kinase (EC:2.7.11.1) | C00002057 | 
| 1636 | ACE, ACE1, CD143, DCP, DCP1, ICH, MVCD3 | angiotensin I converting enzyme (EC:3.4.15.1) | C00002057 | 
| 153 | ADRB1, ADRB1R, B1AR, BETA1AR, RHR | adrenoceptor beta 1 | C00002057 | 
| 154 | ADRB2, ADRB2R, ADRBR, B2AR, BAR, BETA2AR | adrenoceptor beta 2, surface | C00002057 | 
| 207 | AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) | C00002057 | 
| 210 | ALAD, ALADH, PBGS | aminolevulinate dehydratase (EC:4.2.1.24) | C00002057 | 
| 216 | ALDH1A1, ALDC, ALDH-E1, ALDH1, ALDH11, PUMB1, RALDH1 | aldehyde dehydrogenase 1 family, member A1 (EC:1.2.1.36) | C00002057 | 
| 240 | ALOX5, 5-LO, 5-LOX, 5LPG, LOG5 | arachidonate 5-lipoxygenase (EC:1.13.11.34) | C00002057 | 
| 262 | AMD1, ADOMETDC, AMD, SAMDC | adenosylmethionine decarboxylase 1 (EC:4.1.1.50) | C00002057 | 
| 269 | AMHR2, AMHR, MISR2, MISRII, MRII | anti-Mullerian hormone receptor, type II (EC:2.7.11.30) | C00002057 | 
| 327 | APEH, AARE, ACPH, APH, D3F15S2, D3S48E, DNF15S2, OPH | acylaminoacyl-peptide hydrolase (EC:3.4.19.1) | C00002057 | 
| 351 | APP, AAA, ABETA, ABPP, AD1, APPI, CTFgamma, CVAP, PN-II, PN2 | amyloid beta (A4) precursor protein | C00002057 | 
| 55082 | ARGLU1 | arginine and glutamate rich 1 | C00002057 | 
| 8874 | ARHGEF7, BETA-PIX, COOL-1, COOL1, Nbla10314, P50, P50BP, P85, P85COOL1, P85SPR, PAK3, PIXB | Rho guanine nucleotide exchange factor (GEF) 7 | C00002057 | 
| 408 | ARRB1, ARB1, ARR1 | arrestin, beta 1 | C00002057 | 
| 546 | ATRX, ATR2, JMS, MRXHF1, RAD54, RAD54L, SFM1, SHS, XH2, XNP, ZNF-HX | alpha thalassemia/mental retardation syndrome X-linked (EC:3.6.4.12) | C00002057 | 
| 572 | BAD, BBC2, BCL2L8 | BCL2-associated agonist of cell death | C00002057 | 
| 581 | BAX, BCL2L4 | BCL2-associated X protein | C00002057 | 
| 596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 | C00002057 | 
| 597 | BCL2A1, ACC-1, ACC-2, BCL2L5, BFL1, GRS, HBPA1 | BCL2-related protein A1 | C00002057 | 
| 627 | BDNF, ANON2, BULN2 | brain-derived neurotrophic factor | C00002057 | 
| 632 | BGLAP, BGP, OC, OCN | bone gamma-carboxyglutamate (gla) protein | C00002057 | 
| 329 | BIRC2, API1, HIAP2, Hiap-2, MIHB, RNF48, c-IAP1, cIAP1 | baculoviral IAP repeat containing 2 | C00002057 | 
| 332 | BIRC5, API4, EPR-1 | baculoviral IAP repeat containing 5 | C00002057 | 
| 648 | BMI1, FLVI2/BMI1, PCGF4, RNF51 | BMI1 polycomb ring finger oncogene | C00002057 | 
| 672 | BRCA1, BRCAI, BRCC1, BROVCA1, IRIS, PNCA4, PPP1R53, PSCP, RNF53 | breast cancer 1, early onset | C00002057 | 
| 689 | BTF3, BETA-NAC, BTF3a, BTF3b, NACB | basic transcription factor 3 | C00002057 | 
| 695 | BTK, AGMX1, AT, ATK, BPK, IMD1, PSCTK1, XLA | Bruton agammaglobulinemia tyrosine kinase (EC:2.7.10.2) | C00002057 | 
| 728 | C5AR1, C5A, C5AR, C5R1, CD88 | complement component 5a receptor 1 | C00002057 | 
| 730 | C7 | complement component 7 | C00002057 | 
| 811 | CALR, CRT, RO, SSA, cC1qR | calreticulin | C00002057 | 
| 830 | CAPZA2, CAPPA2, CAPZ | capping protein (actin filament) muscle Z-line, alpha 2 | C00002057 | 
| 9607 | CARTPT, CART | CART prepropeptide | C00002057 | 
| 834 | CASP1, ICE, IL1BC, P45 | caspase 1, apoptosis-related cysteine peptidase (EC:3.4.22.36) | C00002057 | 
| 836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) | C00002057 | 
| 842 | CASP9, APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56 | caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) | C00002057 | 
| 867 | CBL, C-CBL, CBL2, FRA11B, NSLL, RNF55 | Cbl proto-oncogene, E3 ubiquitin protein ligase | C00002057 | 
| 11335 | CBX3, HECH, HP1-GAMMA, HP1Hs-gamma | chromobox homolog 3 | C00002057 | 
| 6360 | CCL16, CKb12, HCC-4, ILINCK, LCC-1, LEC, LMC, Mtn-1, NCC-4, NCC4, SCYA16, SCYL4 | chemokine (C-C motif) ligand 16 | C00002057 | 
| 6352 | CCL5, D17S136E, RANTES, SCYA5, SIS-delta, SISd, TCP228, eoCP | chemokine (C-C motif) ligand 5 | C00002057 | 
| 890 | CCNA2, CCN1, CCNA | cyclin A2 | C00002057 | 
| 891 | CCNB1, CCNB | cyclin B1 | C00002057 | 
| 595 | CCND1, BCL1, D11S287E, PRAD1, U21B31 | cyclin D1 | C00002057 | 
| 894 | CCND2, KIAK0002 | cyclin D2 | C00002057 | 
| 898 | CCNE1, CCNE | cyclin E1 | C00002057 | 
| 901 | CCNG2 | cyclin G2 | C00002057 | 
| 1234 | CCR5, CC-CKR-5, CCCKR5, CCR-5, CD195, CKR-5, CKR5, CMKBR5, IDDM22 | chemokine (C-C motif) receptor 5 (gene/pseudogene) | C00002057 | 
| 1235 | CCR6, BN-1, C-C_CKR-6, CC-CKR-6, CCR-6, CD196, CKR-L3, CKRL3, CMKBR6, DCR2, DRY6, GPR29, GPRCY4, STRL22 | chemokine (C-C motif) receptor 6 | C00002057 | 
| 9973 | CCS | copper chaperone for superoxide dismutase | C00002057 | 
| 920 | CD4, CD4mut | CD4 molecule | C00002057 | 
| 4179 | CD46, AHUS2, MCP, MIC10, TLX, TRA2.10 | CD46 molecule, complement regulatory protein | C00002057 | 
| 966 | CD59, 16.3A5, 1F5, EJ16, EJ30, EL32, G344, HRF-20, HRF20, MAC-IP, MACIF, MEM43, MIC11, MIN1, MIN2, MIN3, MIRL, MSK21, p18-20 | CD59 molecule, complement regulatory protein | C00002057 | 
| 993 | CDC25A, CDC25A2 | cell division cycle 25A (EC:3.1.3.48) | C00002057 | 
| 990 | CDC6, CDC18L, HsCDC18, HsCDC6 | cell division cycle 6 | C00002057 | 
| 999 | CDH1, Arc-1, CD324, CDHE, ECAD, LCAM, UVO | cadherin 1, type 1, E-cadherin (epithelial) | C00002057 | 
| 8621 | CDK13, CDC2L, CDC2L5, CHED, hCDK13 | cyclin-dependent kinase 13 (EC:2.7.11.23 2.7.11.22) | C00002057 | 
| 1019 | CDK4, CMM3, PSK-J3 | cyclin-dependent kinase 4 (EC:2.7.11.22) | C00002057 | 
| 1021 | CDK6, PLSTIRE | cyclin-dependent kinase 6 (EC:2.7.11.22) | C00002057 | 
| 1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | C00002057 | 
| 1027 | CDKN1B, CDKN4, KIP1, MEN1B, MEN4, P27KIP1 | cyclin-dependent kinase inhibitor 1B (p27, Kip1) | C00002057 | 
| 1051 | CEBPB, C/EBP-beta, CRP2, IL6DBP, LAP, LIP, NF-IL6, TCF5 | CCAAT/enhancer binding protein (C/EBP), beta | C00002057 | 
| 1062 | CENPE, CENP-E, KIF10, PPP1R61 | centromere protein E, 312kDa | C00002057 | 
| 1106 | CHD2, EEOC | chromodomain helicase DNA binding protein 2 (EC:3.6.4.12) | C00002057 | 
| 1135 | CHRNA2 | cholinergic receptor, nicotinic, alpha 2 (neuronal) | C00002057 | 
| 1136 | CHRNA3, LNCR2, NACHRA3, PAOD2 | cholinergic receptor, nicotinic, alpha 3 (neuronal) | C00002057 | 
| 1137 | CHRNA4, BFNC, EBN, EBN1, NACHR, NACHRA4, NACRA4 | cholinergic receptor, nicotinic, alpha 4 (neuronal) | C00002057 | 
| 1138 | CHRNA5, LNCR2 | cholinergic receptor, nicotinic, alpha 5 (neuronal) | C00002057 | 
| 8973 | CHRNA6, CHNRA6 | cholinergic receptor, nicotinic, alpha 6 (neuronal) | C00002057 | 
| 1139 | CHRNA7, CHRNA7-2, NACHRA7 | cholinergic receptor, nicotinic, alpha 7 (neuronal) | C00002057 | 
| 1141 | CHRNB2, EFNL3, nAChRB2 | cholinergic receptor, nicotinic, beta 2 (neuronal) | C00002057 | 
| 1143 | CHRNB4 | cholinergic receptor, nicotinic, beta 4 (neuronal) | C00002057 | 
| 1160 | CKMT2, SMTCK | creatine kinase, mitochondrial 2 (sarcomeric) (EC:2.7.3.2) | C00002057 | 
| 100196409 | C00002057 | ||
| 1164 | CKS2, CKSHS2 | CDC28 protein kinase regulatory subunit 2 | C00002057 | 
| 23155 | CLCC1, MCLC | chloride channel CLIC-like 1 | C00002057 | 
| 1182 | CLCN3, CLC3, ClC-3 | chloride channel, voltage-sensitive 3 | C00002057 | 
| 1192 | CLIC1, G6, NCC27 | chloride intracellular channel 1 | C00002057 | 
| 1272 | CNTN1, F3, GP135 | contactin 1 | C00002057 | 
| 1382 | CRABP2, CRABP-II, RBP6 | cellular retinoic acid binding protein 2 | C00002057 | 
| 1385 | CREB1, CREB | cAMP responsive element binding protein 1 | C00002057 | 
| 1437 | CSF2, GMCSF | colony stimulating factor 2 (granulocyte-macrophage) | C00002057 | 
| 3579 | CXCR2, CD182, CDw128b, CMKAR2, IL8R2, IL8RA, IL8RB | chemokine (C-X-C motif) receptor 2 | C00002057 | 
| 2833 | CXCR3, CD182, CD183, CKR-L2, CMKAR3, GPR9, IP10-R, Mig-R, MigR | chemokine (C-X-C motif) receptor 3 | C00002057 | 
| 7852 | CXCR4, CD184, D2S201E, FB22, HM89, HSY3RR, LAP3, LCR1, LESTR, NPY3R, NPYR, NPYRL, NPYY3R, WHIM | chemokine (C-X-C motif) receptor 4 | C00002057 | 
| 54205 | CYCS, CYC, HCS, THC4 | cytochrome c, somatic | C00002057 | 
| 1583 | CYP11A1, CYP11A, CYPXIA1, P450SCC | cytochrome P450, family 11, subfamily A, polypeptide 1 (EC:1.14.15.6) | C00002057 | 
| 1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) | C00002057 | 
| 1544 | CYP1A2, CP12, P3-450, P450(PA) | cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) | C00002057 | 
| 1592 | CYP26A1, CP26, CYP26, P450RAI, P450RAI1 | cytochrome P450, family 26, subfamily A, polypeptide 1 (EC:1.14.-.-) | C00002057 | 
| 1553 | CYP2A13, CPAD, CYP2A, CYPIIA13 | cytochrome P450, family 2, subfamily A, polypeptide 13 (EC:1.14.14.1) | C00002057 | 
| 1548 | CYP2A6, CPA6, CYP2A, CYP2A3, CYPIIA6, P450C2A, P450PB | cytochrome P450, family 2, subfamily A, polypeptide 6 (EC:1.14.14.1) | C00002057 | 
| 1555 | CYP2B6, CPB6, CYP2B, CYP2B7, CYP2B7P, CYPIIB6, EFVM, IIB1, P450 | cytochrome P450, family 2, subfamily B, polypeptide 6 (EC:1.14.14.1) | C00002057 | 
| 1576 | CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1 | cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) | C00002057 | 
| 1621 | DBH, DBM | dopamine beta-hydroxylase (dopamine beta-monooxygenase) (EC:1.14.17.1) | C00002057 | 
| 54876 | DCAF16, C4orf30 | DDB1 and CUL4 associated factor 16 | C00002057 | 
| 1642 | DDB1, DDBA, UV-DDB1, XAP1, XPCE, XPE, XPE-BF | damage-specific DNA binding protein 1, 127kDa | C00002057 | 
| 1649 | DDIT3, CEBPZ, CHOP, CHOP-10, CHOP10, GADD153 | DNA-damage-inducible transcript 3 | C00002057 | 
| 10521 | DDX17, P72, RH70 | DEAD (Asp-Glu-Ala-Asp) box helicase 17 (EC:3.6.4.13) | C00002057 | 
| 9191 | DEDD, CASP8IP1, DEDD1, DEFT, FLDED1 | death effector domain containing | C00002057 | 
| 1677 | DFFB, CAD, CPAN, DFF-40, DFF2, DFF40 | DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase) | C00002057 | 
| 1719 | DHFR, DHFRP1, DYR | dihydrofolate reductase (EC:1.5.1.3) | C00002057 | 
| 1725 | DHPS, DHS, DS, MIG13 | deoxyhypusine synthase (EC:2.5.1.46) | C00002057 | 
| 1777 | DNASE2, DNASE2A, DNL, DNL2 | deoxyribonuclease II, lysosomal (EC:3.1.22.1) | C00002057 | 
| 10059 | DNM1L, DLP1, DRP1, DVLP, DYMPLE, EMPF, HDYNIV | dynamin 1-like (EC:3.6.5.5) | C00002057 | 
| 1841 | DTYMK, CDC8, PP3731, TMPK, TYMK | deoxythymidylate kinase (thymidylate kinase) (EC:2.7.4.9) | C00002057 | 
| 1856 | DVL2 | dishevelled segment polarity protein 2 | C00002057 | 
| 1783 | DYNC1LI2, DNCLI2, LIC2 | dynein, cytoplasmic 1, light intermediate chain 2 | C00002057 | 
| 1869 | E2F1, E2F-1, RBAP1, RBBP3, RBP3 | E2F transcription factor 1 | C00002057 | 
| 1870 | E2F2, E2F-2 | E2F transcription factor 2 | C00002057 | 
| 1871 | E2F3, E2F-3 | E2F transcription factor 3 | C00002057 | 
| 1874 | E2F4, E2F-4 | E2F transcription factor 4, p107/p130-binding | C00002057 | 
| 1875 | E2F5, E2F-5 | E2F transcription factor 5, p130-binding | C00002057 | 
| 1909 | EDNRA, ET-A, ETA, ETA-R, ETAR, ETRA, hET-AR | endothelin receptor type A | C00002057 | 
| 1938 | EEF2, EEF-2, EF-2, EF2, SCA26 | eukaryotic translation elongation factor 2 | C00002057 | 
| 1956 | EGFR, ERBB, ERBB1, HER1, PIG61, mENA | epidermal growth factor receptor (EC:2.7.10.1) | C00002057 | 
| 5610 | EIF2AK2, EIF2AK1, PKR, PRKR | eukaryotic translation initiation factor 2-alpha kinase 2 (EC:2.7.11.1 2.7.10.2) | C00002057 | 
| 1978 | EIF4EBP1, 4E-BP1, 4EBP1, BP-1, PHAS-I | eukaryotic translation initiation factor 4E binding protein 1 | C00002057 | 
| 27436 | EML4, C2orf2, ELP120, EMAP-4, EMAPL4, ROPP120 | echinoderm microtubule associated protein like 4 | C00002057 | 
| 2042 | EPHA3, EK4, ETK, ETK1, HEK, HEK4, TYRO4 | EPH receptor A3 (EC:2.7.10.1) | C00002057 | 
| 2049 | EPHB3, ETK2, HEK2, TYRO6 | EPH receptor B3 (EC:2.7.10.1) | C00002057 | 
| 2056 | EPO, EP, MVCD2 | erythropoietin | C00002057 | 
| 7430 | EZR, CVIL, CVL, VIL2 | ezrin | C00002057 | 
| 2147 | F2, PT, RPRGL2, THPH1 | coagulation factor II (thrombin) (EC:3.4.21.5) | C00002057 | 
| 355 | FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6 | Fas cell surface death receptor | C00002057 | 
| 356 | FASLG, ALPS1B, APT1LG1, APTL, CD178, CD95-L, CD95L, FASL, TNFSF6 | Fas ligand (TNF superfamily, member 6) | C00002057 | 
| 2195 | FAT1, CDHF7, CDHR8, FAT, ME5, hFat1 | FAT atypical cadherin 1 | C00002057 | 
| 9638 | FEZ1 | fasciculation and elongation protein zeta 1 (zygin I) | C00002057 | 
| 2247 | FGF2, BFGF, FGF-2, FGFB, HBGF-2 | fibroblast growth factor 2 (basic) | C00002057 | 
| 2322 | FLT3, CD135, FLK-2, FLK2, STK1 | fms-related tyrosine kinase 3 (EC:2.7.10.1) | C00002057 | 
| 2328 | FMO3, FMOII, TMAU, dJ127D3.1 | flavin containing monooxygenase 3 (EC:1.14.13.8 1.14.13.148) | C00002057 | 
| 2335 | FN1, CIG, ED-B, FINC, FN, FNZ, GFND, GFND2, LETS, MSF | fibronectin 1 | C00002057 | 
| 2348 | FOLR1, FBP, FOLR | folate receptor 1 (adult) | C00002057 | 
| 2353 | FOS, AP-1, C-FOS, p55 | FBJ murine osteosarcoma viral oncogene homolog | C00002057 | 
| 2354 | FOSB, AP-1, G0S3, GOS3, GOSB | FBJ murine osteosarcoma viral oncogene homolog B | C00002057 | 
| 2308 | FOXO1, FKH1, FKHR, FOXO1A | forkhead box O1 | C00002057 | 
| 2534 | FYN, SLK, SYN, p59-FYN | FYN oncogene related to SRC, FGR, YES (EC:2.7.10.2) | C00002057 | 
| 2582 | GALE, SDR1E1 | UDP-galactose-4-epimerase (EC:5.1.3.2) | C00002057 | 
| 2624 | GATA2, DCML, MONOMAC, NFE1B | GATA binding protein 2 | C00002057 | 
| 2643 | GCH1, DYT14, DYT5, DYT5a, GCH, GTP-CH-1, GTPCH1, HPABH4B | GTP cyclohydrolase 1 (EC:3.5.4.16) | C00002057 | 
| 2657 | GDF1, DORV, DTGA3, RAI | growth differentiation factor 1 | C00002057 | 
| 11010 | GLIPR1, CRISP7, GLIPR, RTVP1 | GLI pathogenesis-related 1 | C00002057 | 
| 2790 | GNG10 | guanine nucleotide binding protein (G protein), gamma 10 | C00002057 | 
| 2803 | GOLGA4, GCP2, GOLG, MU-RMS-40.18, p230 | golgin A4 | C00002057 | 
| 2876 | GPX1, GPXD, GSHPX1 | glutathione peroxidase 1 (EC:1.11.1.9) | C00002057 | 
| 30206 | C00002057 | ||
| 2931 | GSK3A | glycogen synthase kinase 3 alpha (EC:2.7.11.1 2.7.11.26) | C00002057 | 
| 2932 | GSK3B | glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) | C00002057 | 
| 2978 | GUCA1A, C6orf131, COD3, CORD14, GCAP, GCAP1, GUCA, GUCA1, dJ139D8.6 | guanylate cyclase activator 1A (retina) | C00002057 | 
| 3094 | HINT1, HINT, NMAN, PKCI-1, PRKCNH1 | histidine triad nucleotide binding protein 1 | C00002057 | 
| 6596 | HLTF, HIP116, HIP116A, HLTF1, RNF80, SMARCA3, SNF2L3, ZBU1 | helicase-like transcription factor | C00002057 | 
| 3159 | HMGA1, HMG-R, HMGA1A, HMGIY | high mobility group AT-hook 1 | C00002057 | 
| 3156 | HMGCR, LDLCQ3 | 3-hydroxy-3-methylglutaryl-CoA reductase (EC:1.1.1.34) | C00002057 | 
| 50809 | HP1BP3, HP1-BP74 | heterochromatin protein 1, binding protein 3 | C00002057 | 
| 3320 | HSP90AA1, EL52, HSP86, HSP89A, HSP90A, HSP90N, HSPC1, HSPCA, HSPCAL1, HSPCAL4, HSPN, Hsp89, Hsp90, LAP2 | heat shock protein 90kDa alpha (cytosolic), class A member 1 | C00002057 | 
| 3422 | IDI1, IPP1, IPPI1 | isopentenyl-diphosphate delta isomerase 1 (EC:5.3.3.2) | C00002057 | 
| 2537 | IFI6, 6-16, FAM14C, G1P3, IFI-6-16, IFI616 | interferon, alpha-inducible protein 6 | C00002057 | 
| 3454 | IFNAR1, AVP, IFN-alpha-REC, IFNAR, IFNBR, IFRC | interferon (alpha, beta and omega) receptor 1 | C00002057 | 
| 3507 | C00002057 | ||
| 3586 | IL10, CSIF, GVHDS, IL-10, IL10A, TGIF | interleukin 10 | C00002057 | 
| 3552 | IL1A, IL-1A, IL1, IL1-ALPHA, IL1F1 | interleukin 1, alpha | C00002057 | 
| 3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta | C00002057 | 
| 3558 | IL2, IL-2, TCGF, lymphokine | interleukin 2 | C00002057 | 
| 3563 | IL3RA, CD123, IL3R, IL3RAY, IL3RX, IL3RY, hIL-3Ra | interleukin 3 receptor, alpha (low affinity) | C00002057 | 
| 3569 | IL6, BSF2, HGF, HSF, IFNB2, IL-6 | interleukin 6 (interferon, beta 2) | C00002057 | 
| 3574 | IL7, IL-7 | interleukin 7 | C00002057 | 
| 3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 | C00002057 | 
| 3578 | IL9, HP40, IL-9, P40 | interleukin 9 | C00002057 | 
| 3638 | INSIG1, CL-6, CL6 | insulin induced gene 1 | C00002057 | 
| 3674 | ITGA2B, BDPLT16, BDPLT2, CD41, CD41B, GP2B, GPIIb, GT, GTA, HPA3 | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | C00002057 | 
| 3683 | ITGAL, CD11A, LFA-1, LFA1A | integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) | C00002057 | 
| 3688 | ITGB1, CD29, FNRB, GPIIA, MDF2, MSK12, VLA-BETA, VLAB | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | C00002057 | 
| 3690 | ITGB3, BDPLT16, BDPLT2, CD61, GP3A, GPIIIa, GT | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | C00002057 | 
| 3713 | IVL | involucrin | C00002057 | 
| 80853 | KDM7A, JHDM1D | lysine (K)-specific demethylase 7A | C00002057 | 
| 3725 | JUN, AP-1, AP1, c-Jun | jun proto-oncogene | C00002057 | 
| 3726 | JUNB, AP-1 | jun B proto-oncogene | C00002057 | 
| 8462 | KLF11, FKLF, FKLF1, MODY7, TIEG2, Tieg3 | Kruppel-like factor 11 | C00002057 | 
| 58508 | KMT2C, HALR, MLL3 | lysine (K)-specific methyltransferase 2C (EC:2.1.1.43) | C00002057 | 
| 3912 | LAMB1, CLM, LIS5 | laminin, beta 1 | C00002057 | 
| 3932 | LCK, LSK, YT16, p56lck, pp58lck | lymphocyte-specific protein tyrosine kinase (EC:2.7.10.2) | C00002057 | 
| 3936 | LCP1, CP64, L-PLASTIN, LC64P, LPL, PLS2 | lymphocyte cytosolic protein 1 (L-plastin) | C00002057 | 
| 3949 | LDLR, FH, FHC, LDLCQ2 | low density lipoprotein receptor | C00002057 | 
| 3981 | LIG4 | ligase IV, DNA, ATP-dependent (EC:6.5.1.1) | C00002057 | 
| 9516 | LITAF, PIG7, SIMPLE, TP53I7 | lipopolysaccharide-induced TNF factor | C00002057 | 
| 9208 | LRRFIP1, FLAP-1, FLAP1, FLIIAP1, GCF-2, GCF2, HUFI-1, TRIP | leucine rich repeat (in FLII) interacting protein 1 | C00002057 | 
| 4050 | LTB, TNFC, TNFSF3, p33 | lymphotoxin beta (TNF superfamily, member 3) | C00002057 | 
| 116068 | LYSMD3 | LysM, putative peptidoglycan-binding, domain containing 3 | C00002057 | 
| 8567 | MADD, DENN, IG20, RAB3GEP | MAP-kinase activating death domain | C00002057 | 
| 378938 | MALAT1, HCN, LINC00047, MALAT-1, NCRNA00047, NEAT2, PRO2853 | metastasis associated lung adenocarcinoma transcript 1 (non-protein coding) | C00002057 | 
| 5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) | C00002057 | 
| 5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) | C00002057 | 
| 5599 | MAPK8, JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1, SAPK1c | mitogen-activated protein kinase 8 (EC:2.7.11.24) | C00002057 | 
| 4170 | MCL1, BCL2L3, EAT, MCL1-ES, MCL1L, MCL1S, Mcl-1, TM, bcl2-L-3, mcl1/EAT | myeloid cell leukemia sequence 1 (BCL2-related) | C00002057 | 
| 80306 | MED28, 1500003D12Rik, EG1, magicin | mediator complex subunit 28 | C00002057 | 
| 4312 | MMP1, CLG, CLGN | matrix metallopeptidase 1 (interstitial collagenase) (EC:3.4.24.7) | C00002057 | 
| 4322 | MMP13, CLG3, MANDP1 | matrix metallopeptidase 13 (collagenase 3) (EC:3.4.24.-) | C00002057 | 
| 4313 | MMP2, CLG4, CLG4A, MMP-II, MONA, TBE-1 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) | C00002057 | 
| 4314 | MMP3, CHDS6, MMP-3, SL-1, STMY, STMY1, STR1 | matrix metallopeptidase 3 (stromelysin 1, progelatinase) (EC:3.4.24.17) | C00002057 | 
| 4316 | MMP7, MMP-7, MPSL1, PUMP-1 | matrix metallopeptidase 7 (matrilysin, uterine) (EC:3.4.24.23) | C00002057 | 
| 4318 | MMP9, CLG4B, GELB, MANDP2, MMP-9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) | C00002057 | 
| 4485 | MST1, D3F15S2, DNF15S2, HGFL, MSP, NF15S2 | macrophage stimulating 1 (hepatocyte growth factor-like) | C00002057 | 
| 4528 | MTIF2 | mitochondrial translational initiation factor 2 | C00002057 | 
| 4605 | MYBL2, B-MYB, BMYB | v-myb avian myeloblastosis viral oncogene homolog-like 2 | C00002057 | 
| 4609 | MYC, MRTL, MYCC, bHLHe39, c-Myc | v-myc avian myelocytomatosis viral oncogene homolog | C00002057 | 
| 4637 | MYL6, ESMLC, LC17, LC17-GI, LC17-NM, LC17A, LC17B, MLC-3, MLC1SM, MLC3NM, MLC3SM | myosin, light chain 6, alkali, smooth muscle and non-muscle | C00002057 | 
| 79923 | NANOG | Nanog homeobox | C00002057 | 
| 4698 | NDUFA5, B13, CI-13KD-B, CI-13kB, NUFM, UQOR13 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 5 (EC:1.6.5.3 1.6.99.3) | C00002057 | 
| 4741 | NEFM, NEF3, NF-M, NFM | neurofilament, medium polypeptide | C00002057 | 
| 4773 | NFATC2, NFAT1, NFATP | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 | C00002057 | 
| 4790 | NFKB1, EBP-1, KBF1, NF-kB1, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, NFkappaB, p105, p50 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | C00002057 | 
| 4794 | NFKBIE, IKBE | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | C00002057 | 
| 4801 | NFYB, CBF-A, CBF-B, HAP3, NF-YB | nuclear transcription factor Y, beta | C00002057 | 
| 51199 | NIN, SCKL7 | ninein (GSK3B interacting protein) | C00002057 | 
| 4832 | NME3, DR-nm23, NDPK-C, NDPKC, NM23-H3, NM23H3, c371H6.2 | NME/NM23 nucleoside diphosphate kinase 3 (EC:2.7.4.6) | C00002057 | 
| 4843 | NOS2, HEP-NOS, INOS, NOS, NOS2A | nitric oxide synthase 2, inducible (EC:1.14.13.39) | C00002057 | 
| 4846 | NOS3, ECNOS, eNOS | nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) | C00002057 | 
| 4915 | NTRK2, GP145-TrkB, TRKB, trk-B | neurotrophic tyrosine kinase, receptor, type 2 (EC:2.7.10.1) | C00002057 | 
| 8473 | OGT, HRNT1, O-GLCNAC | O-linked N-acetylglucosamine (GlcNAc) transferase (EC:2.4.1.255) | C00002057 | 
| 4986 | OPRK1, K-OR-1, KOR, KOR-1, OPRK | opioid receptor, kappa 1 | C00002057 | 
| 4999 | ORC2, ORC2L | origin recognition complex, subunit 2 | C00002057 | 
| 79646 | PANK3 | pantothenate kinase 3 (EC:2.7.1.33) | C00002057 | 
| 5071 | PARK2, AR-JP, LPRS2, PDJ, PRKN | parkin RBR E3 ubiquitin protein ligase | C00002057 | 
| 3355109 | C00002057 | ||
| 142 | PARP1, ADPRT, ADPRT_1, ADPRT1, ARTD1, PARP, PARP-1, PPOL, pADPRT-1 | poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) | C00002057 | 
| 5111 | PCNA | proliferating cell nuclear antigen | C00002057 | 
| 5155 | PDGFB, IBGC5, PDGF-2, PDGF2, SIS, SSV, c-sis | platelet-derived growth factor beta polypeptide | C00002057 | 
| 5159 | PDGFRB, CD140B, IBGC4, IMF1, JTK12, PDGFR, PDGFR-1, PDGFR1 | platelet-derived growth factor receptor, beta polypeptide (EC:2.7.10.1) | C00002057 | 
| 51317 | PHF21A, BHC80 | PHD finger protein 21A | C00002057 | 
| 23469 | PHF3 | PHD finger protein 3 | C00002057 | 
| 35178 | C00002057 | ||
| 5281 | PIGF | phosphatidylinositol glycan anchor biosynthesis, class F (EC:2.7.8.1) | C00002057 | 
| 5290 | PIK3CA, CLOVE, CWS5, MCAP, MCM, MCMTC, PI3K, p110-alpha | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha (EC:2.7.11.1 2.7.1.153) | C00002057 | 
| 5586 | PKN2, PAK2, PRK2, PRKCL2, PRO2042, Pak-2 | protein kinase N2 (EC:2.7.11.13) | C00002057 | 
| 5327 | PLAT, T-PA, TPA | plasminogen activator, tissue (EC:3.4.21.68) | C00002057 | 
| 5328 | PLAU, ATF, BDPLT5, QPD, UPA, URK, u-PA | plasminogen activator, urokinase (EC:3.4.21.73) | C00002057 | 
| 5329 | PLAUR, CD87, U-PAR, UPAR, URKR | plasminogen activator, urokinase receptor | C00002057 | 
| 5337 | PLD1 | phospholipase D1, phosphatidylcholine-specific (EC:3.1.4.4) | C00002057 | 
| 5338 | PLD2 | phospholipase D2 (EC:3.1.4.4) | C00002057 | 
| 57480 | PLEKHG1, ARHGEF41 | pleckstrin homology domain containing, family G (with RhoGef domain) member 1 | C00002057 | 
| 5409 | PNMT, PENT, PNMTase | phenylethanolamine N-methyltransferase (EC:2.1.1.28) | C00002057 | 
| 8228 | PNPLA4, DXS1283E, GS2, iPLA2eta | patatin-like phospholipase domain containing 4 (EC:3.1.1.3) | C00002057 | 
| 5445 | PON2 | paraoxonase 2 (EC:3.1.1.2 3.1.1.81) | C00002057 | 
| 5450 | POU2AF1, BOB1, OBF-1, OBF1, OCAB | POU class 2 associating factor 1 | C00002057 | 
| 5451 | POU2F1, OCT1, OTF1, oct-1B | POU class 2 homeobox 1 | C00002057 | 
| 5460 | POU5F1, OCT3, OCT4, OTF-3, OTF3, OTF4, Oct-3, Oct-4 | POU class 5 homeobox 1 | C00002057 | 
| 5523 | PPP2R3A, PPP2R3, PR130, PR72 | protein phosphatase 2, regulatory subunit B'', alpha (EC:3.1.3.16) | C00002057 | 
| 5577 | PRKAR2B, PRKAR2, RII-BETA | protein kinase, cAMP-dependent, regulatory, type II, beta (EC:2.7.11.1) | C00002057 | 
| 5578 | PRKCA, AAG6, PKC-alpha, PKCA, PRKACA | protein kinase C, alpha (EC:2.7.11.13) | C00002057 | 
| 5579 | PRKCB, PKC-beta, PKCB, PRKCB1, PRKCB2 | protein kinase C, beta (EC:2.7.11.13) | C00002057 | 
| 5589 | PRKCSH, AGE-R2, G19P1, PCLD, PKCSH, PLD1 | protein kinase C substrate 80K-H (EC:2.7.11.1) | C00002057 | 
| 5590 | PRKCZ, PKC-ZETA, PKC2 | protein kinase C, zeta (EC:2.7.11.13) | C00002057 | 
| 55119 | PRPF38B, NET1, RP11-293A10.1 | pre-mRNA processing factor 38B | C00002057 | 
| 23215 | PRRC2C, BAT2-iso, BAT2D1, BAT2L2, XTP2 | proline-rich coiled-coil 2C | C00002057 | 
| 5644 | PRSS1, TRP1, TRY1, TRY4, TRYP1 | protease, serine, 1 (trypsin 1) (EC:3.4.21.4) | C00002057 | 
| 5694 | PSMB6, DELTA, LMPY, Y | proteasome (prosome, macropain) subunit, beta type, 6 (EC:3.4.25.1) | C00002057 | 
| 5724 | PTAFR, PAFR | platelet-activating factor receptor | C00002057 | 
| 58155 | PTBP2, PTB, PTBLP, brPTB, nPTB, nPTB5, nPTB6, nPTB7, nPTB8 | polypyrimidine tract binding protein 2 | C00002057 | 
| 5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) | C00002057 | 
| 5786 | PTPRA, HEPTP, HLPR, HPTPA, HPTPalpha, LRP, PTPA, PTPRL2, R-PTP-alpha, RPTPA | protein tyrosine phosphatase, receptor type, A (EC:3.1.3.48) | C00002057 | 
| 5806 | PTX3, TNFAIP5, TSG-14 | pentraxin 3, long | C00002057 | 
| 5870 | RAB6A, RAB6 | RAB6A, member RAS oncogene family | C00002057 | 
| 10111 | RAD50, NBSLD, RAD502, hRad50 | RAD50 homolog (S. cerevisiae) | C00002057 | 
| 5894 | RAF1, CRAF, NS5, Raf-1, c-Raf | v-raf-1 murine leukemia viral oncogene homolog 1 (EC:2.7.11.1) | C00002057 | 
| 5916 | RARG, NR1B3, RARC | retinoic acid receptor, gamma | C00002057 | 
| 5925 | RB1, OSRC, RB, p105-Rb, pRb, pp110 | retinoblastoma 1 | C00002057 | 
| 5930 | RBBP6, MY038, P2P-R, PACT, RBQ-1, SNAMA | retinoblastoma binding protein 6 | C00002057 | 
| 146713 | RBFOX3, FOX-3, FOX3, HRNBP3, NEUN | RNA binding protein, fox-1 homolog (C. elegans) 3 | C00002057 | 
| 5933 | RBL1, CP107, PRB1, p107 | retinoblastoma-like 1 (p107) | C00002057 | 
| 5934 | RBL2, P130, Rb2 | retinoblastoma-like 2 (p130) | C00002057 | 
| 58517 | RBM25, NET52, RED120, RNPC7, S164, Snu71, fSAP94 | RNA binding motif protein 25 | C00002057 | 
| 5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A | C00002057 | 
| 5994 | RFXAP | regulatory factor X-associated protein | C00002057 | 
| 5996 | RGS1, 1R20, BL34, IER1, IR20 | regulator of G-protein signaling 1 | C00002057 | 
| 6018 | RLF, ZN-15L, ZNF292L | rearranged L-myc fusion | C00002057 | 
| 6130 | RPL7A, L7A, SURF3, TRUP | ribosomal protein L7a | C00002057 | 
| 6230 | RPS25, S25 | ribosomal protein S25 | C00002057 | 
| 57521 | RPTOR, KOG1, Mip1 | regulatory associated protein of MTOR, complex 1 | C00002057 | 
| 862 | RUNX1T1, AML1T1, CBFA2T1, CDR, ETO, MTG8, ZMYND2 | runt-related transcription factor 1; translocated to, 1 (cyclin D-related) | C00002057 | 
| 6281 | S100A10, 42C, ANX2L, ANX2LG, CAL1L, CLP11, Ca[1], GP11, P11, p10 | S100 calcium binding protein A10 | C00002057 | 
| 44263 | C00002057 | ||
| 66234 | C00002057 | ||
| 9169 | SCAF11, CASP11, SFRS2IP, SIP1, SRRP129, SRSF2IP | SR-related CTD-associated factor 11 | C00002057 | 
| 23480 | SEC61G, SSS1 | Sec61 gamma subunit | C00002057 | 
| 10955 | SERINC3, AIGP1, DIFF33, SBBI99, TDE, TDE1, TMS-1 | serine incorporator 3 | C00002057 | 
| 5054 | SERPINE1, PAI, PAI-1, PAI1, PLANH1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | C00002057 | 
| 871 | SERPINH1, AsTP3, CBP1, CBP2, HSP47, OI10, PPROM, RA-A47, SERPINH2, gp46 | serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1) | C00002057 | 
| 51639 | SF3B14, HSPC175, Ht006, P14, SAP14, SF3B14a | splicing factor 3B, 14 kDa subunit | C00002057 | 
| 10572 | SIVA1, CD27BP, SIVA, Siva-1, Siva-2 | SIVA1, apoptosis-inducing factor | C00002057 | 
| 6573 | SLC19A1, CHMD, FOLT, IFC1, REFC, RFC1 | solute carrier family 19 (folate transporter), member 1 | C00002057 | 
| 10559 | SLC35A1, CDG2F, CMPST, CST, hCST | solute carrier family 35 (CMP-sialic acid transporter), member A1 | C00002057 | 
| 25800 | SLC39A6, LIV-1 | solute carrier family 39 (zinc transporter), member 6 | C00002057 | 
| 9351 | SLC9A3R2, E3KARP, NHE3RF2, NHERF-2, NHERF2, OCTS2, SIP-1, SIP1, TKA-1 | solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 2 | C00002057 | 
| 4093 | SMAD9, MADH6, MADH9, PPH2, SMAD8, SMAD8A, SMAD8B | SMAD family member 9 | C00002057 | 
| 6615 | SNAI1, SLUGH2, SNA, SNAH, SNAIL, SNAIL1, dJ710H13.1 | snail family zinc finger 1 | C00002057 | 
| 6591 | SNAI2, SLUG, SLUGH1, SNAIL2, WS2D | snail family zinc finger 2 | C00002057 | 
| 6619 | SNAPC3, PTFbeta, SNAP50 | small nuclear RNA activating complex, polypeptide 3, 50kDa | C00002057 | 
| 6622 | SNCA, NACP, PARK1, PARK4, PD1 | synuclein, alpha (non A4 component of amyloid precursor) | C00002057 | 
| 252672 | C00002057 | ||
| 6647 | SOD1, ALS, ALS1, IPOA, SOD, hSod1, homodimer | superoxide dismutase 1, soluble (EC:1.15.1.1) | C00002057 | 
| 6654 | SOS1, GF1, GGF1, GINGF, HGF, NS4 | son of sevenless homolog 1 (Drosophila) | C00002057 | 
| 9043 | SPAG9, CT89, HLC-6, HLC4, JIP-4, JIP4, JLP, PHET, PIG6 | sperm associated antigen 9 | C00002057 | 
| 6696 | SPP1, BNSP, BSPI, ETA-1, OPN | secreted phosphoprotein 1 | C00002057 | 
| 6714 | SRC, ASV, SRC1, c-SRC, p60-Src | v-src avian sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (EC:2.7.10.2) | C00002057 | 
| 6720 | SREBF1, SREBP-1c, SREBP1, bHLHd1 | sterol regulatory element binding transcription factor 1 | C00002057 | 
| 400410 | ST20, HCCS-1 | suppressor of tumorigenicity 20 | C00002057 | 
| 6770 | STAR, STARD1 | steroidogenic acute regulatory protein | C00002057 | 
| 6773 | STAT2, ISGF-3, P113, STAT113 | signal transducer and activator of transcription 2, 113kDa | C00002057 | 
| 6774 | STAT3, APRF, HIES | signal transducer and activator of transcription 3 (acute-phase response factor) | C00002057 | 
| 6777 | STAT5B, STAT5 | signal transducer and activator of transcription 5B | C00002057 | 
| 6778 | STAT6, D12S1644, IL-4-STAT, STAT6B, STAT6C | signal transducer and activator of transcription 6, interleukin-4 induced | C00002057 | 
| 8614 | STC2, STC-2, STCRP | stanniocalcin 2 | C00002057 | 
| 10963 | STIP1, HOP, IEF-SSP-3521, P60, STI1, STI1L | stress-induced-phosphoprotein 1 | C00002057 | 
| 10494 | STK25, SOK1, YSK1 | serine/threonine kinase 25 (EC:2.7.11.1) | C00002057 | 
| 6814 | STXBP3, MUNC18-3, MUNC18C, PSP, UNC-18C | syntaxin binding protein 3 | C00002057 | 
| 6827 | SUPT4H1, SPT4, SPT4H, SUPT4H | suppressor of Ty 4 homolog 1 (S. cerevisiae) | C00002057 | 
| 8407 | TAGLN2, HA1756 | transgelin 2 | C00002057 | 
| 57551 | TAOK1, KFC-B, MAP3K16, MARKK, PSK-2, PSK2, TAO1, hKFC-B, hTAOK1 | TAO kinase 1 (EC:2.7.11.1) | C00002057 | 
| 7027 | TFDP1, DP1, DRTF1, Dp-1 | transcription factor Dp-1 | C00002057 | 
| 7980 | TFPI2, PP5, REF1, TFPI-2 | tissue factor pathway inhibitor 2 | C00002057 | 
| 7037 | TFRC, CD71, T9, TFR, TFR1, TR, TRFR, p90 | transferrin receptor | C00002057 | 
| 7054 | TH, DYT14, DYT5b, TYH | tyrosine hydroxylase (EC:1.14.16.2) | C00002057 | 
| 9984 | THOC1, HPR1, P84, P84N5 | THO complex 1 | C00002057 | 
| 7076 | TIMP1, CLGI, EPA, EPO, HCI, TIMP | TIMP metallopeptidase inhibitor 1 | C00002057 | 
| 7078 | TIMP3, HSMRK222, K222, K222TA2, SFD | TIMP metallopeptidase inhibitor 3 | C00002057 | 
| 7079 | TIMP4 | TIMP metallopeptidase inhibitor 4 | C00002057 | 
| 7082 | TJP1, ZO-1 | tight junction protein 1 | C00002057 | 
| 440026 | TMEM41B | transmembrane protein 41B | C00002057 | 
| 7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor | C00002057 | 
| 7132 | TNFRSF1A, CD120a, FPF, MS5, TBP1, TNF-R, TNF-R-I, TNF-R55, TNFAR, TNFR1, TNFR1-d2, TNFR55, TNFR60, p55, p55-R, p60 | tumor necrosis factor receptor superfamily, member 1A | C00002057 | 
| 11073 | TOPBP1, TOP2BP1 | topoisomerase (DNA) II binding protein 1 | C00002057 | 
| 7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 | C00002057 | 
| 7175 | TPR | translocated promoter region, nuclear basket protein | C00002057 | 
| 29896 | TRA2A, AWMS1, HSU53209 | transformer 2 alpha homolog (Drosophila) | C00002057 | 
| 28951 | TRIB2, C5FW, GS3955, TRB2 | tribbles pseudokinase 2 | C00002057 | 
| 9321 | TRIP11, ACG1A, CEV14, GMAP-210, TRIP-11, TRIP230 | thyroid hormone receptor interactor 11 | C00002057 | 
| 7253 | TSHR, CHNG1, LGR3, hTSHR-I | thyroid stimulating hormone receptor | C00002057 | 
| 7277 | TUBA4A, H2-ALPHA, TUBA1 | tubulin, alpha 4a | C00002057 | 
| 203068 | TUBB, M40, OK/SW-cl.56, TUBB1, TUBB5 | tubulin, beta class I | C00002057 | 
| 7291 | TWIST1, ACS3, BPES2, BPES3, CRS1, SCS, TWIST, bHLHa38 | twist family bHLH transcription factor 1 | C00002057 | 
| 10190 | TXNDC9, APACD, PHLP3 | thioredoxin domain containing 9 | C00002057 | 
| 23350 | U2SURP, SR140, fSAPa | U2 snRNP-associated SURP domain containing | C00002057 | 
| 10054 | UBA2, ARX, SAE2 | ubiquitin-like modifier activating enzyme 2 | C00002057 | 
| 11065 | UBE2C, UBCH10, dJ447F3.2 | ubiquitin-conjugating enzyme E2C (EC:6.3.2.19) | C00002057 | 
| 7329 | UBE2I, C358B7.1, P18, UBC9 | ubiquitin-conjugating enzyme E2I (EC:6.3.2.19) | C00002057 | 
| 7337 | UBE3A, ANCR, AS, E6-AP, EPVE6AP, HPVE6A | ubiquitin protein ligase E3A (EC:6.3.2.19) | C00002057 | 
| 51569 | UFM1, BM-002, C13orf20 | ubiquitin-fold modifier 1 | C00002057 | 
| 7360 | UGP2, UDPG, UDPGP, UDPGP2, UGP1, UGPP1, UGPP2, pHC379 | UDP-glucose pyrophosphorylase 2 (EC:2.7.7.9) | C00002057 | 
| 54659 | UGT1A3, UDPGT, UDPGT_1-3, UGT-1C, UGT1-03, UGT1.3, UGT1C | UDP glucuronosyltransferase 1 family, polypeptide A3 (EC:2.4.1.17) | C00002057 | 
| 54657 | UGT1A4, HUG-BR2, UDPGT, UDPGT_1-4, UGT-1D, UGT1-04, UGT1.4, UGT1D | UDP glucuronosyltransferase 1 family, polypeptide A4 (EC:2.4.1.17) | C00002057 | 
| 54600 | UGT1A9, HLUGP4, LUGP4, UDPGT, UDPGT_1-9, UGT-1I, UGT1-09, UGT1-9, UGT1.9, UGT1AI, UGT1I | UDP glucuronosyltransferase 1 family, polypeptide A9 (EC:2.4.1.17) | C00002057 | 
| 9094 | UNC119, HRG4, POC7, POC7A | unc-119 homolog (C. elegans) | C00002057 | 
| 7386 | UQCRFS1, RIP1, RIS1, RISP, UQCR5 | ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 (EC:1.10.2.2) | C00002057 | 
| 7412 | VCAM1, CD106, INCAM-100 | vascular cell adhesion molecule 1 | C00002057 | 
| 7422 | VEGFA, MVCD1, VEGF, VPF | vascular endothelial growth factor A | C00002057 | 
| 7431 | VIM, CTRCT30 | vimentin | C00002057 | 
| 7450 | VWF, F8VWF, VWD | von Willebrand factor | C00002057 | 
| 331 | XIAP, API3, BIRC4, IAP-3, ILP1, MIHA, XLP2, hIAP-3, hIAP3 | X-linked inhibitor of apoptosis | C00002057 | 
| 7503 | XIST, DXS1089, DXS399E, LINC00001, NCRNA00001, SXI1, swd66 | X inactive specific transcript (non-protein coding) | C00002057 | 
| 7525 | YES1, HsT441, P61-YES, Yes, c-yes | v-yes-1 Yamaguchi sarcoma viral oncogene homolog 1 (EC:2.7.10.2) | C00002057 | 
| 23318 | ZCCHC11, PAPD3, TUT4 | zinc finger, CCHC domain containing 11 (EC:2.7.7.52) | C00002057 | 
| 84240 | ZCCHC9, PPP1R41 | zinc finger, CCHC domain containing 9 | C00002057 | 
| 6935 | ZEB1, AREB6, BZP, DELTAEF1, FECD6, NIL2A, PPCD3, TCF8, ZFHEP, ZFHX1A | zinc finger E-box binding homeobox 1 | C00002057 | 
| 7538 | ZFP36, G0S24, GOS24, NUP475, RNF162A, TIS11, TTP, zfp-36 | ZFP36 ring finger protein | C00002057 | 
| 51663 | ZFR, ZFR1 | zinc finger RNA binding protein | C00002057 | 
| 23613 | ZMYND8, PRKCBP1, PRO2893, RACK7 | zinc finger, MYND-type containing 8 | C00002057 | 
| 7705 | ZNF146, OZF | zinc finger protein 146 | C00002057 | 
| 100129482 | ZNF37BP, KOX21, ZNF37B | zinc finger protein 37B, pseudogene | C00002057 | 
| 90333 | ZNF468 | zinc finger protein 468 | C00002057 | 
| 100289635 | ZNF605 | zinc finger protein 605 | C00002057 | 
| 100129842 | ZNF737, ZNF102 | zinc finger protein 737 | C00002057 | 
| OMIM | preferred title | UniProt | 
|---|---|---|
| #100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism | P20309 | 
| #103780 | Alcohol dependence | P08172 P14416 P31645 | 
| #612069 | Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia; als10 | Q13148 | 
| #614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 | Q99720 | 
| #602025 | Body mass index quantitative trait locus 9; bmiq9 | P41968 | 
| #300615 | Brunner syndrome | P21397 | 
| #115200 | Cardiomyopathy, dilated, 1a; cmd1a | P02545 | 
| #212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism | P02545 | 
| #212140 | Carnitine deficiency, systemic primary; cdsp | O76082 | 
| #605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 | P02545 | 
| #114500 | Colorectal cancer; crc | P84022 | 
| #162800 | Cyclic neutropenia | P08246 | 
| #612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 | P51681 | 
| #609535 | Drug metabolism, poor, cyp2c19-related | P33261 | 
| #608902 | Drug metabolism, poor, cyp2d6-related | P10635 | 
| #237500 | Dubin-johnson syndrome; djs | Q92887 | 
| #181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 | P02545 | 
| #600513 | Epilepsy, nocturnal frontal lobe, 1; enfl1 | P43681 | 
| #605375 | Epilepsy, nocturnal frontal lobe, 3; enfl3 | P17787 | 
| #610353 | Epilepsy, nocturnal frontal lobe, 4; enfl4 | Q15822 | 
| #615040 | Episodic pain syndrome, familial, 1; feps1 | O75762 | 
| #615363 | Estrogen resistance; estrr | P03372 | 
| #600274 | Frontotemporal dementia; ftd | P10636 | 
| #613659 | Gastric cancer | P04626 | 
| #137215 | Gastric cancer, hereditary diffuse; hdgc | P04626 | 
| #231095 | Ghosal hematodiaphyseal dysplasia; ghdd | P24557 | 
| #137800 | Glioma susceptibility 1; glm1 | P04626 | 
| #610140 | Heart-hand syndrome, slovenian type | P02545 | 
| #609423 | Human immunodeficiency virus type 1, susceptibility to | P41597 P51681 | 
| #176670 | Hutchinson-gilford progeria syndrome; hgps | P02545 | 
| #237450 | Hyperbilirubinemia, rotor type; hblrr | Q9NPD5 Q9Y6L6 | 
| #603932 | Intervertebral disc disease; idd | P14780 | 
| #151660 | Lipodystrophy, familial partial, type 2; fpld2 | P02545 | 
| #613795 | Loeys-dietz syndrome, type 3; lds3 | P84022 | 
| #613688 | Long qt syndrome 2; lqt2 | Q12809 | 
| #211980 | Lung cancer | P00533 P04626 | 
| #608516 | Major depressive disorder; mdd | P08172 | 
| #248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada | P02545 | 
| %300852 | Mental retardation, x-linked 88; mrx88 | P50052 | 
| #613073 | Metaphyseal anadysplasia 2; mandp2 | P14780 | 
| #265000 | Multiple pterygium syndrome, escobar variant; evmps | P07510 | 
| #253290 | Multiple pterygium syndrome, lethal type; lmps | P02708 P07510 Q07001 | 
| #126200 | Multiple sclerosis, susceptibility to; ms | P08575 | 
| #613205 | Muscular dystrophy, congenital, lmna-related | P02545 | 
| #159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b | P02545 | 
| #608931 | Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency | P11230 | 
| #608930 | Myasthenic syndrome, congenital, fast-channel | P02708 Q07001 | 
| #601462 | Myasthenic syndrome, congenital, slow-channel; sccms | P02708 P11230 Q07001 | 
| #159900 | Myoclonic dystonia | P14416 | 
| #202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 | P08246 | 
| #601665 | Obesity | P32245 | 
| #164230 | Obsessive-compulsive disorder; ocd | P31645 | 
| #604715 | Orthostatic intolerance | P23975 | 
| #259730 | Osteopetrosis, autosomal recessive 3; optb3 | P00918 | 
| #167000 | Ovarian cancer | P04626 | 
| #260540 | Parkinson-dementia syndrome | P10636 | 
| #613135 | Parkinsonism-dystonia, infantile; pkdys | Q01959 | 
| #172700 | Pick disease of brain | P10636 | 
| #601399 | Platelet disorder, familial, with associated myeloid malignancy | Q01196 | 
| #607276 | Resting heart rate, variation in | P08588 | 
| #275210 | Restrictive dermopathy, lethal | P02545 | 
| #180300 | Rheumatoid arthritis; ra | Q9H015 | 
| #604906 | Schizophrenia 9; sczd9 | P49798 | 
| #181500 | Schizophrenia; sczd | P49798 | 
| #608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive | P08575 | 
| #609620 | Short qt syndrome 1; sqt1 | Q12809 | 
| #612052 | Smoking as a quantitative trait locus 3; sqtl3 | P30532 P32297 | 
| #607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 | Q9NUW8 | 
| #601104 | Supranuclear palsy, progressive, 1; psnp1 | P10636 | 
| #190300 | Tremor, hereditary essential, 1; etm1 | P35462 | 
| #610379 | West nile virus, susceptibility to | P51681 | 
| #112100 | Yt blood group antigen | P22303 | 
| KEGG | name | UniProt | 
|---|---|---|
| H00286 | Crohn's disease | O76082
                            (related) Q9H015 (related) | 
| H00525 | Disorders of fatty-acid oxidation | O76082
                            (related) | 
| H00016 | Oral cancer | P00533
                            (related) P00533 (marker) | 
| H00017 | Esophageal cancer | P00533
                            (related) P35354 (related) | 
| H00018 | Gastric cancer | P00533
                            (related) P04626 (related) | 
| H00022 | Bladder cancer | P00533
                            (related) P04626 (related) | 
| H00028 | Choriocarcinoma | P00533
                            (related) P03956 (related) P04626 (related) | 
| H00030 | Cervical cancer | P00533
                            (related) P04626 (related) | 
| H00042 | Glioma | P00533
                            (related) P00533 (marker) | 
| H00055 | Laryngeal cancer | P00533
                            (related) P00533 (marker) | 
| H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) | P00918
                            (related) | 
| H00436 | Osteopetrosis | P00918
                            (related) | 
| H00264 | Charcot-Marie-Tooth disease (CMT) | P02545
                            (related) | 
| H00294 | Dilated cardiomyopathy (DCM) | P02545
                            (related) | 
| H00420 | Familial partial lipodystrophy (FPL) | P02545
                            (related) | 
| H00563 | Emery-Dreifuss muscular dystrophy | P02545
                            (related) | 
| H00590 | Congenital muscular dystrophies (CMD/MDC) | P02545
                            (related) | 
| H00593 | Limb-girdle muscular dystrophy (LGMD) | P02545
                            (related) | 
| H00601 | Hutchinson-Gilford progeria syndrome | P02545
                            (related) | 
| H00663 | Restrictive dermopathy | P02545
                            (related) | 
| H00665 | Mandibuloacral dysplasia | P02545
                            (related) | 
| H01216 | Left ventricular noncompaction (LVNC) | P02545
                            (related) | 
| H00770 | Congenital myasthenic syndrome | P02708
                            (related) P11230 (related) Q07001 (related) | 
| H00986 | Multiple pterygium syndrome | P02708
                            (related) P07510 (related) Q07001 (related) | 
| H00026 | Endometrial Cancer | P03372
                            (marker) P04626 (related) Q92731 (marker) | 
| H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) | P04150
                            (related) | 
| H00019 | Pancreatic cancer | P04626
                            (related) | 
| H00027 | Ovarian cancer | P04626
                            (related) | 
| H00031 | Breast cancer | P04626
                            (related) P04626 (marker) | 
| H00046 | Cholangiocarcinoma | P04626
                            (related) P35354 (related) | 
| H00093 | Combined immunodeficiencies (CIDs) | P06239
                            (related) | 
| H00079 | Asthma | P07550
                            (related) | 
| H00100 | Neutropenic disorders | P08246
                            (related) | 
| H00091 | T-B+Severe combined immunodeficiencies (SCIDs) | P08575
                            (related) | 
| H00036 | Osteosarcoma | P08684
                            (marker) | 
| H00058 | Amyotrophic lateral sclerosis (ALS) | P10636
                            (related) Q13148 (related) | 
| H00077 | Progressive supranuclear palsy (PSP) | P10636
                            (related) | 
| H00078 | Frontotemporal lobar degeneration (FTLD) | P10636
                            (related) | 
| H01205 | Coumarin resistance | P11712
                            (related) | 
| H00025 | Penile cancer | P14780
                            (related) P35354 (related) | 
| H00479 | Metaphyseal dysplasias | P14780
                            (related) | 
| H00807 | Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) | P17787
                            (related) P43681 (related) Q15822 (related) | 
| H00548 | Brunner syndrome | P21397
                            (related) | 
| H01031 | Orthostatic intolerance (OI) | P23975
                            (related) | 
| H00490 | Diaphyseal dysplasia with anemia (Ghosal) | P24557
                            (related) | 
| H01171 | Poor drug metabolism (PM) | P33261
                            (related) | 
| H00480 | Non-syndromic X-linked mental retardation | P50052
                            (related) | 
| H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) | Q01196
                            (related) Q01196 (marker) | 
| H00003 | Acute myeloid leukemia (AML) | Q01196
                            (related) Q01196 (marker) Q13951 (marker) | 
| H00004 | Chronic myeloid leukemia (CML) | Q01196
                            (related) | 
| H00978 | Thrombocytopenia (THC) | Q01196
                            (related) | 
| H00720 | Long QT syndrome | Q12809
                            (related) | 
| H00725 | Short QT syndrome | Q12809
                            (related) | 
| H00208 | Hyperbilirubinemia | Q92887
                            (related) | 
| H00063 | Spinocerebellar ataxia (SCA) | Q9NUW8
                            (related) | 
| MESH or OMIM | name | KNApSAcK metabolite | 
|---|---|---|
| D015746 | Abdominal Pain | C00002057 | 
| D000014 | Abnormalities, Drug-Induced | C00002057 | 
| D058186 | Acute Kidney Injury | C00002057 | 
| D000405 | Akinetic Mutism | C00002057 | 
| D000437 | Alcoholism | C00002057 | 
| D000544 | Alzheimer Disease | C00002057 | 
| D000647 | Amnesia | C00002057 | 
| D019969 | Amphetamine-Related Disorders | C00002057 | 
| D017542 | Aneurysm, Ruptured | C00002057 | 
| D000860 | Anoxia | C00002057 | 
| D001008 | Anxiety Disorders | C00002057 | 
| D001014 | Aortic Aneurysm | C00002057 | 
| D001018 | Aortic Diseases | C00002057 | 
| D001049 | Apnea | C00002057 | 
| D001145 | Arrhythmias, Cardiac | C00002057 | 
| D001161 | Arteriosclerosis | C00002057 | 
| D001168 | Arthritis | C00002057 | 
| D001176 | Arthrogryposis | C00002057 | 
| D001259 | Ataxia | C00002057 | 
| D050197 | Atherosclerosis | C00002057 | 
| D001281 | Atrial Fibrillation | C00002057 | 
| D054537 | Atrioventricular Block | C00002057 | 
| D001289 | Attention Deficit Disorder with Hyperactivity | C00002057 | 
| D001308 | Auditory Perceptual Disorders | C00002057 | 
| D001714 | Bipolar Disorder | C00002057 | 
| D001919 | Bradycardia | C00002057 | 
| D001927 | Brain Diseases | C00002057 | 
| D001929 | Brain Edema | C00002057 | 
| D001930 | Brain Injuries | C00002057 | 
| D001943 | Breast Neoplasms | C00002057 | 
| D002114 | Calcinosis | C00002057 | 
| D002289 | Carcinoma, Non-Small-Cell Lung | C00002057 | 
| D002294 | Carcinoma, Squamous Cell | C00002057 | 
| D005117 | Cardiac Complexes, Premature | C00002057 | 
| D009202 | Cardiomyopathies | C00002057 | 
| D002318 | Cardiovascular Diseases | C00002057 | 
| D002375 | Catalepsy | C00002057 | 
| D002543 | Cerebral Hemorrhage | C00002057 | 
| D002561 | Cerebrovascular Disorders | C00002057 | 
| D018290 | Cervical Intraepithelial Neoplasia | C00002057 | 
| D002637 | Chest Pain | C00002057 | 
| D019970 | Cocaine-Related Disorders | C00002057 | 
| D003072 | Cognition Disorders | C00002057 | 
| D003093 | Colitis, Ulcerative | C00002057 | 
| D003110 | Colonic Neoplasms | C00002057 | 
| D019955 | Conduct Disorder | C00002057 | 
| D003251 | Constriction, Pathologic | C00002057 | 
| D003324 | Coronary Artery Disease | C00002057 | 
| D003329 | Coronary Vasospasm | C00002057 | 
| D003490 | Cyanosis | C00002057 | 
| D003693 | Delirium | C00002057 | 
| D003866 | Depressive Disorder | C00002057 | 
| D003865 | Depressive Disorder, Major | C00002057 | 
| D003872 | Dermatitis | C00002057 | 
| D003924 | Diabetes Mellitus, Type 2 | C00002057 | 
| D003928 | Diabetic Nephropathies | C00002057 | 
| D003967 | Diarrhea | C00002057 | 
| D004244 | Dizziness | C00002057 | 
| D056486 | Drug-Induced Liver Injury | C00002057 | 
| D064420 | Drug-Related Side Effects and Adverse Reactions | C00002057 | 
| D004409 | Dyskinesia, Drug-Induced | C00002057 | 
| D004421 | Dystonia | C00002057 | 
| D020821 | Dystonic Disorders | C00002057 | 
| D001068 | Eating Disorders | C00002057 | 
| D004487 | Edema | C00002057 | 
| D004802 | Eosinophilia | C00002057 | 
| D007172 | Erectile Dysfunction | C00002057 | 
| D004890 | Erythema | C00002057 | 
| D005076 | Exanthema | C00002057 | 
| D005234 | Fatty Liver | C00002057 | 
| D005317 | Fetal Growth Retardation | C00002057 | 
| D005334 | Fever | C00002057 | 
| D005921 | Glomerulonephritis | C00002057 | 
| D044882 | Glucose Metabolism Disorders | C00002057 | 
| D006261 | Headache | C00002057 | 
| D006258 | Head and Neck Neoplasms | C00002057 | 
| D006323 | Heart Arrest | C00002057 | 
| D006606 | Hiccup | C00002057 | 
| D006930 | Hyperalgesia | C00002057 | 
| D006940 | Hyperemia | C00002057 | 
| D006948 | Hyperkinesis | C00002057 | 
| D006973 | Hypertension | C00002057 | 
| D006976 | Hypertension, Pulmonary | C00002057 | 
| D006984 | Hypertrophy | C00002057 | 
| D006985 | Hyperventilation | C00002057 | 
| D018476 | Hypokinesia | C00002057 | 
| D007022 | Hypotension | C00002057 | 
| D007035 | Hypothermia | C00002057 | 
| D007246 | Infertility | C00002057 | 
| D007249 | Inflammation | C00002057 | 
| D007333 | Insulin Resistance | C00002057 | 
| D055959 | Intervertebral Disc Degeneration | C00002057 | 
| D002542 | Intracranial Embolism and Thrombosis | C00002057 | 
| D007511 | Ischemia | C00002057 | 
| D007805 | Language Development Disorders | C00002057 | 
| D007859 | Learning Disorders | C00002057 | 
| D008107 | Liver Diseases | C00002057 | 
| D008133 | Long QT Syndrome | C00002057 | 
| D008171 | Lung Diseases | C00002057 | 
| D008175 | Lung Neoplasms | C00002057 | 
| D008545 | Melanoma | C00002057 | 
| D008569 | Memory Disorders | C00002057 | 
| D028361 | Mitochondrial Diseases | C00002057 | 
| D009041 | Motion Sickness | C00002057 | 
| D009069 | Movement Disorders | C00002057 | 
| D020267 | MPTP Poisoning | C00002057 | 
| D009133 | Muscular Atrophy | C00002057 | 
| D009203 | Myocardial Infarction | C00002057 | 
| D015428 | Myocardial Reperfusion Injury | C00002057 | 
| D009207 | Myoclonus | C00002057 | 
| D009325 | Nausea | C00002057 | 
| D009336 | Necrosis | C00002057 | 
| D009361 | Neoplasm Invasiveness | C00002057 | 
| D009362 | Neoplasm Metastasis | C00002057 | 
| D009369 | Neoplasms | C00002057 | 
| D009374 | Neoplasms, Experimental | C00002057 | 
| D009389 | Neovascularization, Pathologic | C00002057 | 
| D009410 | Nerve Degeneration | C00002057 | 
| D009422 | Nervous System Diseases | C00002057 | 
| D009436 | Neural Tube Defects | C00002057 | 
| D019954 | Neurobehavioral Manifestations | C00002057 | 
| D019636 | Neurodegenerative Diseases | C00002057 | 
| D054081 | Neuronal Migration Disorders | C00002057 | 
| D020258 | Neurotoxicity Syndromes | C00002057 | 
| D009669 | Nose Neoplasms | C00002057 | 
| D009759 | Nystagmus, Pathologic | C00002057 | 
| D009765 | Obesity | C00002057 | 
| D009845 | Oligospermia | C00002057 | 
| D010146 | Pain | C00002057 | 
| D010182 | Pancreatic Diseases | C00002057 | 
| D010190 | Pancreatic Neoplasms | C00002057 | 
| D016584 | Panic Disorder | C00002057 | 
| D030361 | Papillomavirus Infections | C00002057 | 
| D010243 | Paralysis | C00002057 | 
| D010291 | Paresis | C00002057 | 
| D010302 | Parkinson Disease, Secondary | C00002057 | 
| D010510 | Periodontal Diseases | C00002057 | 
| D010523 | Peripheral Nervous System Diseases | C00002057 | 
| D016491 | Peripheral Vascular Diseases | C00002057 | 
| D011041 | Poisoning | C00002057 | 
| D011086 | Polycythemia | C00002057 | 
| D011183 | Postoperative Complications | C00002057 | 
| D011297 | Prenatal Exposure Delayed Effects | C00002057 | 
| D003668 | Pressure Ulcer | C00002057 | 
| D011507 | Proteinuria | C00002057 | 
| D011537 | Pruritus | C00002057 | 
| D011605 | Psychoses, Substance-Induced | C00002057 | 
| D011618 | Psychotic Disorders | C00002057 | 
| D011654 | Pulmonary Edema | C00002057 | 
| D011693 | Purpura | C00002057 | 
| D012021 | Reflex, Abnormal | C00002057 | 
| D051436 | Renal Insufficiency, Chronic | C00002057 | 
| D015427 | Reperfusion Injury | C00002057 | 
| D012120 | Respiration Disorders | C00002057 | 
| D012131 | Respiratory Insufficiency | C00002057 | 
| D015619 | Respiratory System Abnormalities | C00002057 | 
| D012164 | Retinal Diseases | C00002057 | 
| D012640 | Seizures | C00002057 | 
| D012798 | Sialorrhea | C00002057 | 
| D012848 | Sinoatrial Block | C00002057 | 
| D012878 | Skin Neoplasms | C00002057 | 
| D012893 | Sleep Disorders | C00002057 | 
| D007319 | Sleep Initiation and Maintenance Disorders | C00002057 | 
| D055752 | Small Cell Lung Carcinoma | C00002057 | 
| D013035 | Spasm | C00002057 | 
| D016137 | Spina Bifida Cystica | C00002057 | 
| D013117 | Spinal Cord Compression | C00002057 | 
| D019956 | Stereotypic Movement Disorder | C00002057 | 
| D013274 | Stomach Neoplasms | C00002057 | 
| D013276 | Stomach Ulcer | C00002057 | 
| D020521 | Stroke | C00002057 | 
| D013345 | Subarachnoid Hemorrhage | C00002057 | 
| D019966 | Substance-Related Disorders | C00002057 | 
| D013375 | Substance Withdrawal Syndrome | C00002057 | 
| D013398 | Sudden Infant Death | C00002057 | 
| D013610 | Tachycardia | C00002057 | 
| D013919 | Thromboangiitis Obliterans | C00002057 | 
| D013927 | Thrombosis | C00002057 | 
| D020323 | Tics | C00002057 | 
| 188890 | TOBACCO ADDICTION, SUSCEPTIBILITY TO | C00002057 | 
| D014029 | Tobacco Use Disorder | C00002057 | 
| D005879 | Tourette Syndrome | C00002057 | 
| D014133 | Tracheal Diseases | C00002057 | 
| D014202 | Tremor | C00002057 | 
| D001745 | Urinary Bladder Diseases | C00002057 | 
| D014652 | Vascular Diseases | C00002057 | 
| D014657 | Vasculitis | C00002057 | 
| D018366 | Vasculitis, Leukocytoclastic, Cutaneous | C00002057 | 
| D018879 | Ventricular Premature Complexes | C00002057 | 
| D014839 | Vomiting | C00002057 | 
| D015430 | Weight Gain | C00002057 |